Clinical Trial Update: Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with cisplatin, radiation, and fluorouracil in stage IIB to IVB nasopharyngeal cancer completed with results posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• FLUOROURACIL (Fluorouracil)
• Radiation therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2013-04-18